IL6 and bladder transitional cell carcinoma: For IL6 (Figure 3H), high expression indicates a poor prognosis in lung squamous cell carcinoma (LUSC) and BLCA, while demonstrating protective effects for KIRC, illustrating the dual aspects of cancer progression.